nChroma Bio has presented new preclinical data supporting its lead [...]

A team from the University of Tokyo and Juntendo University [...]

Cue Biopharma and ImmunoScape have entered an exclusive collaboration and [...]

Heidelberg Pharma has reported further clinical activity from its Phase [...]

Nucleome Therapeutics and Oxford University scientists have mapped the 3D [...]

Discover Pharma caught up with Danny Galbraith, chief scientific officer [...]

Nanexa says its long-acting subcutaneous technology could reduce the dosing [...]

Veeva Systems and OpenEvidence have announced a long-term partnership to [...]

Doron Therapeutics has dosed the first patients in its Phase [...]

Enterome has received Fast Track designation from the US Food [...]